EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses

Kush K Pandey iD, Bikash R Sahoo iD, Asit K Pattnaik iD

Viruses · 09.06.2024 · 16 (6) · 936

DOI: 10.3390/v16060936 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 09.06.2024. Verfasst von Kush K Pandey und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA. Hauptthemen laut MEDLINE: Nanoparticles, Viral Vaccines. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Nebraska-Lincoln.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccines are one of the most effective medical interventions, playing a pivotal role in treating infectious diseases. Although traditional vaccines comprise killed, inactivated, or live-attenuated pathogens that have resulted in protective immune responses, the negative consequences of their administration have been well appreciated. Modern vaccines have evolved to contain purified antigenic subunits, epitopes, or antigen-encoding mRNAs, rendering them relatively safe. However, reduced humoral and cellular responses pose major challenges to these subunit vaccines. Protein nanoparticle (PNP)-based vaccines have garnered substantial interest in recent years for their ability to present a repetitive array of antigens for improving immunogenicity and enhancing protective responses. Discovery and characterisation of naturally occurring PNPs from various living organisms such as bacteria, archaea, viruses, insects, and eukaryotes, as well as computationally designed structures and approaches to link antigens to the PNPs, have paved the way for unprecedented advances in the field of vaccine technology. In this review, we focus on some of the widely used naturally occurring and optimally designed PNPs for their suitability as promising vaccine platforms for displaying native-like antigens from human viral pathogens for protective immune responses. Such platforms hold great promise in combating emerging and re-emerging infectious viral diseases and enhancing vaccine efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesViral VaccinesHumansAnimalsVirus DiseasesVirusesAntigens, ViralVaccines, Subunit

Stichwörter der Autor:innen

computationally designed nanoparticlesencapsulinferritinlumazine synthaseprotein nanoparticlesviral vaccines

Substanzen

Viral VaccinesAntigens, ViralVaccines, Subunit

Autor:innen und Institutionen

  • School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
  • Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.

ORCID-Profile: Kush K Pandey, Bikash R Sahoo, Asit K Pattnaik

Förderung

  • University of Nebraska-Lincoln

Zitieren

APA

Pandey, K. K., Sahoo, B. R., & Pattnaik, A. K. (2024). Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses. Viruses, 16(6), 936. https://doi.org/10.3390/v16060936

Vancouver

Pandey KK, Sahoo BR, Pattnaik AK. Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses. Viruses. 2024;16(6):936. doi:10.3390/v16060936

BibTeX
@article{Pandey2024,
  author = {Pandey, Kush K and Sahoo, Bikash R and Pattnaik, Asit K},
  title = {Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {6},
  pages = {936},
  doi = {10.3390/v16060936}
}
Kostenlos starten →